<?xml version="1.0" encoding="windows-1252"?>

<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title><![CDATA[Active Biotech]]></title>
<description><![CDATA[Press releases from Active Biotech]]></description>
<language>eng</language>
<link>http://www.activebiotech.com</link>
<copyright>Copyright (c)2008 Active Biotech</copyright>
<docs>http://blogs.law.harvard.edu/tech/rss</docs>
<generator>Hugin - http://www.hugingroup.com/</generator>
<managingEditor>cws@huginonline.com</managingEditor>
<webMaster>cws@huginonline.com</webMaster>
<ttl>10</ttl>
<image>
<title><![CDATA[Active Biotech]]></title>
<url>http://www.activebiotech.com/logo.gif</url>
<link>http://www.activebiotech.com</link>
<width>195</width>
<height>98</height>
</image>

<item>
<title><![CDATA[Active Biotech AB Bokslutsrapport januari - december 2011 ]]></title>
<pubDate>Thu, 16 Feb 2012 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201202/1586222.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Year-end Report January - December 2011]]></title>
<pubDate>Thu, 16 Feb 2012 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201202/1586221.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs prostatacancerprojekt TASQ i fas I klinisk studie som kombinationsterapi]]></title>
<pubDate>Mon, 23 Jan 2012 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201201/1579257.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's Prostate Cancer Project TASQ in Phase I Combination Therapy Trial]]></title>
<pubDate>Mon, 23 Jan 2012 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201201/1579256.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presenterar på  JP Morgan 30th Annual Healthcare Conference   ]]></title>
<pubDate>Wed, 4 Jan 2012 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201201/1574672.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at  the JP Morgan 30th Annual Healthcare Conference   ]]></title>
<pubDate>Wed, 4 Jan 2012 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201201/1574671.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs valberedning utsedd]]></title>
<pubDate>Thu, 10 Nov 2011 16:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201111/1562969.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's election committee appointed]]></title>
<pubDate>Thu, 10 Nov 2011 16:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201111/1562968.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Delårsrapport januari - september 2011]]></title>
<pubDate>Thu, 3 Nov 2011 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201111/1560313.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Interim Report January - September 2011 ]]></title>
<pubDate>Thu, 3 Nov 2011 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201111/1560312.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Information angående Active Biotechs läkemedelskandidat laquinimod]]></title>
<pubDate>Wed, 2 Nov 2011 15:18:56 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201111/1560206.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Information regarding Active Biotech's candidate drug laquinimod]]></title>
<pubDate>Wed, 2 Nov 2011 15:18:56 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201111/1560205.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[LÄKEMEDELSKANDIDATEN LAQUINIMOD - EN LOVANDE UNIK ORAL BEHANDLING MOT RRMS ]]></title>
<pubDate>Wed, 19 Oct 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201110/1555871.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[INVESTIGATIONAL LAQUINIMOD DEMONSTRATES ITS POTENTIAL AS A NEW ORAL TREATMENT FOR RRMS]]></title>
<pubDate>Wed, 19 Oct 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201110/1555870.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs prostatacancerprojekt TASQ presenterat i Journal of Clinical Oncology]]></title>
<pubDate>Tue, 20 Sep 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201109/1548082.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's Prostate Cancer Project TASQ Featured in Journal of Clinical Oncology]]></title>
<pubDate>Tue, 20 Sep 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201109/1548081.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Delårsrapport januari - juni 2011]]></title>
<pubDate>Thu, 11 Aug 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201108/1537778.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Interim Report January - June 2011]]></title>
<pubDate>Thu, 11 Aug 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201108/1537777.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[RESULTAT FRÅN FAS III-STUDIEN BRAVO STÄRKER LAQUINIMODS UNIKA PROFIL FÖR BEHANDLING AV MULTIPEL SKLEROS]]></title>
<pubDate>Mon, 1 Aug 2011 13:41:08 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201108/1535270.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[RESULTS OF PHASE III BRAVO TRIAL REINFORCE UNIQUE PROFILE OF LAQUINIMOD FOR MULTIPLE SCLEROSIS TREATMENT ]]></title>
<pubDate>Mon, 1 Aug 2011 13:41:08 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201108/1535269.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Antal aktier och röster i Active Biotech]]></title>
<pubDate>Thu, 30 Jun 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201106/1526544.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Number of shares and votes in Active Biotech]]></title>
<pubDate>Thu, 30 Jun 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201106/1526543.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presenterar på Jefferies 2011 Global Healthcare Conference]]></title>
<pubDate>Wed, 8 Jun 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201106/1521832.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at the Jefferies 2011 Global Healthcare Conference]]></title>
<pubDate>Wed, 8 Jun 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201106/1521831.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Antal aktier och röster i Active Biotech]]></title>
<pubDate>Tue, 31 May 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201105/1519825.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Number of shares and votes in Active Biotech]]></title>
<pubDate>Tue, 31 May 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201105/1519824.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presenterar data rörande projektet 57-57 på EULAR]]></title>
<pubDate>Thu, 26 May 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201105/1518852.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Presents Data regarding the 57-57 Project at EULAR]]></title>
<pubDate>Thu, 26 May 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201105/1518851.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Årsstämma i Active Biotech AB]]></title>
<pubDate>Fri, 6 May 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201105/1512817.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Annual General Meeting of Active Biotech AB]]></title>
<pubDate>Fri, 6 May 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201105/1512816.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Antal aktier och röster i Active Biotech]]></title>
<pubDate>Fri, 29 Apr 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201104/1510261.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Number of shares and votes in Active Biotech]]></title>
<pubDate>Fri, 29 Apr 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201104/1510260.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Delårsrapport januari - mars 2011]]></title>
<pubDate>Thu, 28 Apr 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201104/1509817.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Interim Report January - March 2011]]></title>
<pubDate>Thu, 28 Apr 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201104/1509816.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs samarbetspartner Teva kommenterar resultaten från studien DEFINE i multipel skleros]]></title>
<pubDate>Tue, 26 Apr 2011 07:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201104/1508762.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's partner Teva comments on DEFINE study results in Multiple Sclerosis]]></title>
<pubDate>Tue, 26 Apr 2011 07:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201104/1508761.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech och Ipsen tecknar brett samarbetsavtal för utveckling och kommersialisering av TASQ inom uro-onkologi]]></title>
<pubDate>Mon, 18 Apr 2011 07:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201104/1507163.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech and Ipsen enter into a broad partnership for the co-development and commercialization of TASQ in uro-oncology]]></title>
<pubDate>Mon, 18 Apr 2011 07:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201104/1507162.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Valberedningen i Active Biotech föreslår ytterligare en ny styrelseledamot]]></title>
<pubDate>Thu, 14 Apr 2011 13:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201104/1506440.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's nomination committee proposes election of an additional new board member]]></title>
<pubDate>Thu, 14 Apr 2011 13:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201104/1506439.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[LAQUINIMOD FÖR ORAL BEHANDLING AV MULTIPEL SKLEROS GAV BÅDE SIGNIFIKANT MINSKAD SJUKDOMSAKTIVITET OCH FUNKTIONSNEDSÄTTNING MED BIBEHÅLLEN GOD SÄKERHET OCH TOLERABILITET]]></title>
<pubDate>Tue, 12 Apr 2011 07:37:35 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201104/1505371.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[ORAL LAQUINIMOD FOR MULTIPLE SCLEROSIS TREATMENT SIGNIFICANTLY REDUCED DISEASE ACTIVITY AND DISABILITY PROGRESSION WHILE PROVIDING GOOD SAFETY AND TOLERABILITY]]></title>
<pubDate>Tue, 12 Apr 2011 07:37:35 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201104/1505370.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Teva håller webbkonferens avseende resultaten från fas III-studien ALLEGRO av oral laquinimod för behandling av multipel skleros]]></title>
<pubDate>Mon, 11 Apr 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201104/1504976.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Teva Announces Webcast on Results from Phase III ALLEGRO Study of Oral Laquinimod in Multiple Sclerosis]]></title>
<pubDate>Mon, 11 Apr 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201104/1504975.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Årsredovisning 2010 Active Biotech AB (publ)]]></title>
<pubDate>Wed, 6 Apr 2011 10:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201104/1503894.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Annual Report 2010 Active Biotech AB (publ)]]></title>
<pubDate>Wed, 6 Apr 2011 10:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201104/1503893.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Kallelse till årsstämma]]></title>
<pubDate>Tue, 5 Apr 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201104/1503149.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Notice of Annual General Meeting of Shareholders]]></title>
<pubDate>Tue, 5 Apr 2011 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201104/1503148.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Helén Tuvesson utsedd till forskningschef på Active Biotech]]></title>
<pubDate>Tue, 15 Mar 2011 15:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201103/1497046.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Helén Tuvesson appointed as new Chief Scientific Officer at Active Biotech]]></title>
<pubDate>Tue, 15 Mar 2011 15:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201103/1497045.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Antal aktier och röster i Active Biotech]]></title>
<pubDate>Mon, 28 Feb 2011 10:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201102/1492745.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Number of shares and votes in Active Biotech]]></title>
<pubDate>Mon, 28 Feb 2011 10:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201102/1492744.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs prostatacancerprojekt TASQ presenterat på 2011 Genitourinary Cancers Symposium]]></title>
<pubDate>Fri, 18 Feb 2011 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201102/1490111.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's TASQ prostate cancer project presented at 2011 Genitourinary Cancers Symposium]]></title>
<pubDate>Fri, 18 Feb 2011 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201102/1490110.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Bokslutsrapport januari - december 2010]]></title>
<pubDate>Thu, 10 Feb 2011 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201102/1487272.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Year-end Report January - December 2010]]></title>
<pubDate>Thu, 10 Feb 2011 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201102/1487271.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech genomför riktad nyemission om 375 miljoner kronor ]]></title>
<pubDate>Thu, 27 Jan 2011 08:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201101/1482792.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech successfully completes private placement of SEK 375 million]]></title>
<pubDate>Thu, 27 Jan 2011 08:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201101/1482791.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech offentliggör placering av nya aktier]]></title>
<pubDate>Wed, 26 Jan 2011 18:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201101/1482721.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech announces launch of private placement of new shares]]></title>
<pubDate>Wed, 26 Jan 2011 18:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201101/1482720.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Antal aktier och röster i Active Biotech]]></title>
<pubDate>Thu, 30 Dec 2010 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201012/1475993.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Number of shares and votes in Active Biotech]]></title>
<pubDate>Thu, 30 Dec 2010 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201012/1475992.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[TEVA OCH ACTIVE BIOTECH OFFENTLIGGÖR FRAMGÅNGSRIKA FAS III-RESULTAT FÖR LAQUINIMOD FÖR ORAL BEHANDLING AV MULTIPEL SKLEROS]]></title>
<pubDate>Thu, 9 Dec 2010 07:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201012/1470713.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[TEVA ANNOUNCES SUCCESSFUL RESULTS OF PHASE III STUDY WITH ORAL LAQUINIMOD FOR MULTIPLE SCLEROSIS]]></title>
<pubDate>Thu, 9 Dec 2010 07:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201012/1470712.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs projekt 57-57 rekommenderat som särläkemedel]]></title>
<pubDate>Thu, 18 Nov 2010 10:08:31 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201011/1463685.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Orphan Medicinal Product Status to Active Biotech's 57-57 project recommended]]></title>
<pubDate>Thu, 18 Nov 2010 10:08:31 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201011/1463684.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs valberedning utsedd]]></title>
<pubDate>Wed, 3 Nov 2010 14:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201011/1458532.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's election committee appointed]]></title>
<pubDate>Wed, 3 Nov 2010 14:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201011/1458531.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Antal aktier och röster i Active Biotech]]></title>
<pubDate>Fri, 29 Oct 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201010/1456522.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Number of shares and votes in Active Biotech]]></title>
<pubDate>Fri, 29 Oct 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201010/1456521.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Delårsrapport januari - september 2010]]></title>
<pubDate>Wed, 27 Oct 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201010/1455518.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Interim Report January - September 2010]]></title>
<pubDate>Wed, 27 Oct 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201010/1455517.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[NYA DATA SOM UTVÄRDERAR LAQUINIMIOD FÖR BEHANDLING AV MULTIPEL SKLEROS UPPVISAR NERVSKYDDANDE EFFEKTER]]></title>
<pubDate>Fri, 15 Oct 2010 15:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201010/1452329.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[NEW DATA EVALUATING LAQUINIMOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS DEMONSTRATE NEUROPROTECTIVE EFFECTS ]]></title>
<pubDate>Fri, 15 Oct 2010 15:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201010/1452328.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Antal aktier och röster i Active Biotech]]></title>
<pubDate>Thu, 30 Sep 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201009/1445804.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Number of shares and votes in Active Biotech]]></title>
<pubDate>Thu, 30 Sep 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201009/1445803.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[LAQUINIMOD I TABLETTFORM UPPVISAR BIBEHÅLLEN EFFEKT OCH SÄKERHET I PATIENTER MED MULTIPEL SKLEROS]]></title>
<pubDate>Mon, 20 Sep 2010 15:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201009/1445409.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[ORAL LAQUINIMOD DEMONSTRATED SUSTAINED EFFICACY AND SAFETY IN PATIENTS WITH MULTIPLE SCLEROSIS]]></title>
<pubDate>Mon, 20 Sep 2010 15:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201009/1445408.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presenterar på UBS Global Life Sciences Conference]]></title>
<pubDate>Thu, 16 Sep 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201009/1444557.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at the UBS Global Life Sciences Conference]]></title>
<pubDate>Thu, 16 Sep 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201009/1444556.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presenterar på Rodman & Renshaw 12th Annual Healthcare Conference ]]></title>
<pubDate>Thu, 9 Sep 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201009/1443196.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at the Rodman & Renshaw 12th Annual Healthcare Conference]]></title>
<pubDate>Thu, 9 Sep 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201009/1443195.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Delårsrapport januari - juni 2010]]></title>
<pubDate>Wed, 11 Aug 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201008/1436938.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Interim report January - June 2010]]></title>
<pubDate>Wed, 11 Aug 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201008/1436937.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Antal aktier och röster i Active Biotech]]></title>
<pubDate>Fri, 30 Jul 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201007/1429854.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Number of shares and votes in Active Biotech]]></title>
<pubDate>Fri, 30 Jul 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201007/1429853.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Antal aktier och röster i Active Biotech]]></title>
<pubDate>Wed, 30 Jun 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201006/1428007.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Number of shares and votes in Active Biotech]]></title>
<pubDate>Wed, 30 Jun 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201006/1428006.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs kapitalmarknadsdag]]></title>
<pubDate>Thu, 10 Jun 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201006/1422766.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Capital Markets Day ]]></title>
<pubDate>Thu, 10 Jun 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201006/1422765.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs prostatacancerprojekt TASQ presenterat på ASCO]]></title>
<pubDate>Mon, 7 Jun 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201006/1421645.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's TASQ prostate cancer project presented at ASCO]]></title>
<pubDate>Mon, 7 Jun 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201006/1421644.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs prostatacancerprojekt presenteras på ASCO]]></title>
<pubDate>Fri, 21 May 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201005/1417724.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's TASQ prostate cancer project to be presented at ASCO ]]></title>
<pubDate>Fri, 21 May 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201005/1417723.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs njurcancerprojekt ANYARA presenteras i Journal of Immunotherapy]]></title>
<pubDate>Tue, 18 May 2010 14:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201005/1416758.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's Renal Cancer Project ANYARA Featured in Journal of Immunotherapy]]></title>
<pubDate>Tue, 18 May 2010 14:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201005/1416757.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech inbjuder till Kapitalmarknadsdag]]></title>
<pubDate>Tue, 18 May 2010 10:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201005/1416589.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech invites to Capital Markets Day ]]></title>
<pubDate>Tue, 18 May 2010 10:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201005/1416588.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs prostatacancerprojekt TASQ presenteras i Molecular Cancer]]></title>
<pubDate>Mon, 17 May 2010 15:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201005/1416362.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's Prostate Cancer Project TASQ Featured in Molecular Cancer]]></title>
<pubDate>Mon, 17 May 2010 15:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201005/1416361.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at the Rodman & Renshaw 6th Annual Global Healthcare Conference ]]></title>
<pubDate>Mon, 17 May 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201005/1415356.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at the Rodman & Renshaw 6th Annual Global Healthcare Conference ]]></title>
<pubDate>Mon, 17 May 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201005/1415355.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Årsstämma i Active Biotech AB]]></title>
<pubDate>Fri, 7 May 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201005/1412540.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Annual General Meeting of Active Biotech AB]]></title>
<pubDate>Fri, 7 May 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201005/1412539.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Antal aktier och röster i Active Biotech]]></title>
<pubDate>Fri, 30 Apr 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201004/1410153.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Number of shares and votes in Active Biotech]]></title>
<pubDate>Fri, 30 Apr 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201004/1410152.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Delårsrapport januari - mars 2010]]></title>
<pubDate>Thu, 22 Apr 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201004/1406539.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Interim report January - March 2010]]></title>
<pubDate>Thu, 22 Apr 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201004/1406538.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Årsredovisning 2009 Active Biotech AB (publ)]]></title>
<pubDate>Tue, 20 Apr 2010 10:05:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201004/1405574.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Annual Report 2009 Active Biotech AB (publ)]]></title>
<pubDate>Tue, 20 Apr 2010 10:05:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201004/1405573.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[NYA DATA VISAR ATT LAQUINIMODS IMMUNMODULERANDE EFFEKT PÅ  MULTIPEL SKLEROS ÄVEN KAN VARA NERVSKYDDANDE  ]]></title>
<pubDate>Thu, 15 Apr 2010 18:29:35 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201004/1404287.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[NEW DATA SUGGEST ORAL LAQUINIMOD MAY CONFER NEUROPROTECTION IN ADDITION TO IMMUNOMODULATION IN THE TREATMENT OF MULTIPLE SCLEROSIS ]]></title>
<pubDate>Thu, 15 Apr 2010 18:29:35 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201004/1404285.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Kallelse till årsstämma]]></title>
<pubDate>Tue, 6 Apr 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201004/1400602.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Notice of Annual General Meeting of Shareholders]]></title>
<pubDate>Tue, 6 Apr 2010 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201004/1400601.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech tillförs 149 miljoner kronor genom en riktad nyemission]]></title>
<pubDate>Thu, 1 Apr 2010 15:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201004/1400338.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech raises SEK 149 million through a directed share issue]]></title>
<pubDate>Thu, 1 Apr 2010 15:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201004/1400337.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Antal aktier och röster i Active Biotech]]></title>
<pubDate>Wed, 31 Mar 2010 16:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201003/1399856.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Number of shares and votes in Active Biotech]]></title>
<pubDate>Wed, 31 Mar 2010 16:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201003/1399855.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Antal aktier och röster i Active Biotech]]></title>
<pubDate>Fri, 26 Feb 2010 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201002/1387883.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Number of shares and votes in Active Biotech]]></title>
<pubDate>Fri, 26 Feb 2010 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201002/1387882.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Bokslutsrapport, januari - december 2009]]></title>
<pubDate>Thu, 11 Feb 2010 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201002/1383190.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Year-end Report, January - December 2009]]></title>
<pubDate>Thu, 11 Feb 2010 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201002/1383189.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Explorativa data presenterade för Active Biotechs  projekt ANYARA]]></title>
<pubDate>Wed, 10 Feb 2010 20:02:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201002/1383211.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Exploratory data presented for Active Biotech's ANYARA project]]></title>
<pubDate>Wed, 10 Feb 2010 20:02:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201002/1383210.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[TEVA FÖRVÄRVAR MARKNADSRÄTTIGHETERNA FÖR LAQUINIMOD I NORDEN OCH BALTIKUM ]]></title>
<pubDate>Mon, 8 Feb 2010 14:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201002/1381481.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[TEVA ACQUIRES MARKETING RIGHTS FOR ORAL LAQUINIMOD IN THE NORDIC AND BALTIC REGIONS ]]></title>
<pubDate>Mon, 8 Feb 2010 14:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/201002/1381480.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Primary endpoint reached in Active Biotech's TASQ Phase II clinical trial in prostate cancer patients]]></title>
<pubDate>Mon, 14 Dec 2009 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200912/1360883.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Primärt mål uppnått i klinisk fas II-prövning för Active Biotechs prostatacancerprojekt TASQ ]]></title>
<pubDate>Mon, 14 Dec 2009 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200912/1360879.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's election committee appointed]]></title>
<pubDate>Thu, 5 Nov 2009 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200911/1352678.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs valberedning utsedd]]></title>
<pubDate>Thu, 5 Nov 2009 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200911/1352677.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Interim Report, January - September 2009]]></title>
<pubDate>Thu, 5 Nov 2009 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200911/1352670.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Delårsrapport, januari - september 2009]]></title>
<pubDate>Thu, 5 Nov 2009 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200911/1352657.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[RhuDex Clinical Development to Continue Following Feedback from Regulatory Authorities]]></title>
<pubDate>Mon, 5 Oct 2009 11:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200910/1345680.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Det brittiska läkemedelsverket ger klartecken för fortsatt klinisk utveckling av RhuDex]]></title>
<pubDate>Mon, 5 Oct 2009 11:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200910/1345676.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's Prostate Cancer Project TASQ Featured in British Journal of Cancer]]></title>
<pubDate>Fri, 25 Sep 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200909/1343587.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs prostatacancerprojekt TASQ presenteras i British Journal of Cancer]]></title>
<pubDate>Fri, 25 Sep 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200909/1343584.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at the UBS Global Life Sciences Conference]]></title>
<pubDate>Thu, 17 Sep 2009 14:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200909/1341991.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presenterar på UBS Global Life Sciences Conference ]]></title>
<pubDate>Thu, 17 Sep 2009 14:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200909/1341985.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[LAQUINIMOD IMMUNOMODULATORY ACTION CONFERS BOTH NEUROPROTECTIVE AND ANTI-INFLAMMATORY PROPERTIES]]></title>
<pubDate>Fri, 11 Sep 2009 15:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200909/1340862.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[LAQUINIMODS IMMUNMODULERANDE MEKANISM HAR BÅDE NERVSKYDDANDE OCH ANTI-INFLAMMATORISKA EGENSKAPER]]></title>
<pubDate>Fri, 11 Sep 2009 15:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200909/1340861.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Laquinimod presentations at ECTRIMS]]></title>
<pubDate>Tue, 8 Sep 2009 16:16:54 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200909/1339945.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Laquinimod presenteras på ECTRIMS]]></title>
<pubDate>Tue, 8 Sep 2009 16:14:28 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200909/1339918.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at the Rodman & Renshaw 11th Annual Healthcare Conference]]></title>
<pubDate>Fri, 4 Sep 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200909/1339336.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presenterar på Rodman & Renshaw 11th Annual Healthcare Conference]]></title>
<pubDate>Fri, 4 Sep 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200909/1339324.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[New information regarding RhuDex(TM)]]></title>
<pubDate>Fri, 7 Aug 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200908/1333185.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Ny information kring RhuDex(TM)]]></title>
<pubDate>Fri, 7 Aug 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200908/1333181.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Interim report January-June 2009]]></title>
<pubDate>Thu, 6 Aug 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200908/1332925.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Delårsrapport januari-juni 2009]]></title>
<pubDate>Thu, 6 Aug 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200908/1332920.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's Cancer Project ANYARA Featured in Journal of Clinical Oncology]]></title>
<pubDate>Tue, 28 Jul 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200907/1330892.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs cancerprojekt ANYARA presenteras i Journal of Clinical Oncology]]></title>
<pubDate>Tue, 28 Jul 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200907/1330891.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Number of shares and votes in Active Biotech]]></title>
<pubDate>Tue, 30 Jun 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200906/1325708.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Antal aktier och röster i Active Biotech]]></title>
<pubDate>Tue, 30 Jun 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200906/1325705.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Teva Completes Enrollment in Second Oral Laquinimod Phase III MS Clinical Trial]]></title>
<pubDate>Thu, 25 Jun 2009 14:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200906/1324912.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[BRAVO-studien för laquinimod fullrekryterad]]></title>
<pubDate>Thu, 25 Jun 2009 14:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200906/1324850.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's rights issue substantially oversubscribed]]></title>
<pubDate>Mon, 15 Jun 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200906/1322365.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs nyemission kraftigt övertecknad  ]]></title>
<pubDate>Mon, 15 Jun 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200906/1322363.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Presents Data regarding the 57-57 SLE Project at EULAR]]></title>
<pubDate>Thu, 11 Jun 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200906/1321784.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presenterar data rörande SLE-projektet 57-57 på EULAR]]></title>
<pubDate>Thu, 11 Jun 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200906/1321782.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Completes Patient Enrollment to TASQ Clinical Phase II study]]></title>
<pubDate>Mon, 8 Jun 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200906/1320096.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Patientrekryteringen till Active Biotechs kliniska fas II-studie för TASQ avslutad]]></title>
<pubDate>Mon, 8 Jun 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200906/1320086.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Completes Patient Enrollment to ANYARA Phase III Clinical Trial]]></title>
<pubDate>Mon, 1 Jun 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200906/1318517.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Patientrekryteringen till Active Biotechs kliniska fas III-studie för ANYARA avslutad]]></title>
<pubDate>Mon, 1 Jun 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200906/1318510.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Announcement of prospectus regarding rights issue in Active Biotech AB (publ)]]></title>
<pubDate>Mon, 18 May 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200905/1315446.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Offentliggörande av prospekt avseende nyemission i Active Biotech AB (publ)]]></title>
<pubDate>Mon, 18 May 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200905/1315442.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Annual General Meeting of Active Biotech AB]]></title>
<pubDate>Fri, 8 May 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200905/1312513.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Årsstämma i Active Biotech AB]]></title>
<pubDate>Fri, 8 May 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200905/1312508.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[NEW DATA ILLUSTRATE NOVEL MECHANISM OF ACTION OF LAQUINIMOD, AN ORAL COMPOUND FOR THE TREATMENT OF MULTIPLE SCLEROSIS ]]></title>
<pubDate>Tue, 28 Apr 2009 15:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200904/1309008.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[NYA RÖN KRING VERKNINGSMEKANISMEN FÖR LAQUINIMOD, EN NY ORAL BEHANDLING AV MULTIPEL SKLEROS]]></title>
<pubDate>Tue, 28 Apr 2009 15:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200904/1308993.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presents S100A9 as a target for quinoline compounds]]></title>
<pubDate>Tue, 28 Apr 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200904/1308461.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presenterar S100A9 som en målmolekyl för quinolinsubstanser]]></title>
<pubDate>Tue, 28 Apr 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200904/1308429.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Interim report January-March 2009]]></title>
<pubDate>Thu, 23 Apr 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200904/1307424.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Delårsrapport januari-mars 2009]]></title>
<pubDate>Thu, 23 Apr 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200904/1307406.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Annual Report 2008 Active Biotech AB (publ)]]></title>
<pubDate>Mon, 6 Apr 2009 08:32:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200904/1303502.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Årsredovisning 2008 Active Biotech AB (publ)]]></title>
<pubDate>Mon, 6 Apr 2009 08:32:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200904/1303495.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[The Board of Active Biotech AB proposes that the Annual General Meeting resolve to make a guaranteed rights issue of approximately SEK 256 M]]></title>
<pubDate>Mon, 6 Apr 2009 08:31:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200904/1303531.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Styrelsen för Active Biotech AB föreslår årsstämman att besluta om en garanterad företrädesemission om cirka 256 MSEK]]></title>
<pubDate>Mon, 6 Apr 2009 08:31:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200904/1303526.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Notice of Annual General Meeting of Shareholders]]></title>
<pubDate>Mon, 6 Apr 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200904/1303521.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Kallelse till årsstämma]]></title>
<pubDate>Mon, 6 Apr 2009 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200904/1303518.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[ORAL LAQUINIMOD FOR MULTIPLE SCLEROSIS GRANTED FAST TRACK STATUS BY FDA]]></title>
<pubDate>Thu, 12 Feb 2009 17:28:47 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200902/1290128.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[LAQUINIMOD FÖR ORAL BEHANDLING AV MULTIPEL SKLEROS ERHÅLLER FAST TRACK-STATUS FRÅN FDA]]></title>
<pubDate>Thu, 12 Feb 2009 17:24:10 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200902/1290119.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB year End Report January-December 2008]]></title>
<pubDate>Thu, 12 Feb 2009 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200902/1289660.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Bokslutsrapport januari-december 2008]]></title>
<pubDate>Thu, 12 Feb 2009 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200902/1289640.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Information from Active Biotech AB's Election Committee]]></title>
<pubDate>Mon, 26 Jan 2009 10:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200901/1284810.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Information från Active Biotech AB:s valberedning ]]></title>
<pubDate>Mon, 26 Jan 2009 10:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200901/1284808.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's Cancer Project ANYARA: Combination with Established Tumor Therapies Promising]]></title>
<pubDate>Wed, 10 Dec 2008 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200812/1276301.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs cancerprojekt ANYARA: Kombination med etablerade tumörläkemedel lovande]]></title>
<pubDate>Wed, 10 Dec 2008 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200812/1276296.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's election committee appointed]]></title>
<pubDate>Fri, 28 Nov 2008 10:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200811/1273823.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs valberedning utsedd]]></title>
<pubDate>Fri, 28 Nov 2008 10:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200811/1273818.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Patientrekryteringen till den kliniska fas III-studien för laquinimod avslutad]]></title>
<pubDate>Tue, 18 Nov 2008 08:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200811/1270579.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Teva Completes Enrollment in Laquinimod Phase III Clinical Trial]]></title>
<pubDate>Tue, 18 Nov 2008 08:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200811/1270575.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Interim Report January-September 2008]]></title>
<pubDate>Fri, 14 Nov 2008 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200811/1269607.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Delårsrapport januari-september 2008]]></title>
<pubDate>Fri, 14 Nov 2008 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200811/1269604.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at the Rodman & Renshaw 10th Annual Healthcare Conference]]></title>
<pubDate>Thu, 6 Nov 2008 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200811/1266750.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Presents New Data regarding the 57-57 SLE Project at American College of Rheumatology Meeting]]></title>
<pubDate>Tue, 28 Oct 2008 12:43:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200810/1263951.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presenterar nya data rörande SLE-projektet 57-57 på American College of Rheumatology]]></title>
<pubDate>Tue, 28 Oct 2008 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200810/1263579.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[New information regarding RhuDex®]]></title>
<pubDate>Fri, 17 Oct 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200810/1260463.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Ny information kring RhuDex®]]></title>
<pubDate>Fri, 17 Oct 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200810/1260462.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[LAQUINIMOD DEMONSTRATED SIGNIFICANT AND SUSTAINED IMPACT ON MULTIPLE SCLEROSIS DISEASE ACTIVITY ]]></title>
<pubDate>Thu, 18 Sep 2008 21:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200809/1252709.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[LAQUINIMOD UPPVISAR SIGNIFIKANT OCH BIBEHÅLLEN VERKAN PÅ SJUKDOMEN MULTIPEL SKLEROS  ]]></title>
<pubDate>Thu, 18 Sep 2008 21:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200809/1252655.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at the UBS 2008 Global Life Sciences Conference ]]></title>
<pubDate>Wed, 17 Sep 2008 11:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200809/1252183.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presenterar på UBS 2008 Global Life Sciences Conference ]]></title>
<pubDate>Wed, 17 Sep 2008 11:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200809/1252178.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Interim Report January-June 2008]]></title>
<pubDate>Wed, 6 Aug 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200808/1241001.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Delårsrapport januari-juni 2008]]></title>
<pubDate>Wed, 6 Aug 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200808/1240980.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Tomas Leanderson appointed new President & CEO for Active Biotech]]></title>
<pubDate>Wed, 23 Jul 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200807/1237751.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Tomas Leanderson ny verkställande direktör i Active Biotech]]></title>
<pubDate>Wed, 23 Jul 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200807/1237749.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[TEVA ENROLLS PATIENTS FOR A SECOND LARGE GLOBAL PHASE III TRIAL OF ORAL LAQUINIMOD ]]></title>
<pubDate>Wed, 16 Jul 2008 08:45:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200807/1236113.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[TEVA REKRYTERAR PATIENTER TILL EN ANDRA STOR GLOBAL REGISTRERINGSGRUNDANDE FAS III-STUDIE AV ORAL LAQUINIMOD FÖR BEHANDLING AV RELAPSERANDE REMITTERANDE MULTIPEL SKLEROS]]></title>
<pubDate>Wed, 16 Jul 2008 08:45:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200807/1236112.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Number of shares and votes in Active Biotech]]></title>
<pubDate>Mon, 30 Jun 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200806/1231405.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Antal aktier och röster i Active Biotech]]></title>
<pubDate>Mon, 30 Jun 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200806/1231399.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[RhuDex® Achieves Positive Results in Clinical Phase IIa Trial]]></title>
<pubDate>Tue, 24 Jun 2008 11:51:33 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200806/1230554.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Positiva resultat för RhuDex® i klinisk fas IIa-studie]]></title>
<pubDate>Tue, 24 Jun 2008 11:48:01 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200806/1230546.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's Novel MS Compound laquinimod Featured in the Scientific Publication The Lancet]]></title>
<pubDate>Fri, 20 Jun 2008 06:26:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200806/1229594.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs orala MS-läkemedel laquinimod presenteras i den vetenskapliga tidskriften The Lancet]]></title>
<pubDate>Fri, 20 Jun 2008 06:25:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200806/1229591.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's new issue fully subscribed]]></title>
<pubDate>Thu, 12 Jun 2008 09:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200806/1227302.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs nyemission fulltecknad]]></title>
<pubDate>Thu, 12 Jun 2008 09:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200806/1227295.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Announcement of prospectus regarding rights issue in Active Biotech AB (publ)]]></title>
<pubDate>Thu, 15 May 2008 13:38:55 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200805/1219736.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Offentliggörande av prospekt avseende nyemission i Active Biotech AB (publ)]]></title>
<pubDate>Thu, 15 May 2008 13:34:30 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200805/1219715.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference]]></title>
<pubDate>Thu, 15 May 2008 10:21:01 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200805/1219597.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech advances ANYARA into Phase III clinical trial]]></title>
<pubDate>Tue, 13 May 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200805/1218474.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs ANYARA går vidare till fas III kliniska prövningar]]></title>
<pubDate>Tue, 13 May 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200805/1218473.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Annual General Meeting of Active Biotech AB]]></title>
<pubDate>Thu, 8 May 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200805/1217249.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Årsstämma i Active Biotech AB]]></title>
<pubDate>Thu, 8 May 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200805/1217246.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Annual Report 2007 Active Biotech AB (publ)]]></title>
<pubDate>Wed, 7 May 2008 14:16:24 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200805/1217006.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Interim Report January-March 2008]]></title>
<pubDate>Thu, 24 Apr 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200804/1212781.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Delårsrapport januari-mars 2008]]></title>
<pubDate>Thu, 24 Apr 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200804/1212772.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Årsredovisning 2007 Active Biotech AB (publ)]]></title>
<pubDate>Wed, 23 Apr 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200804/1212119.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Preclinical data presented for Active Biotech's ANYARA technology]]></title>
<pubDate>Tue, 15 Apr 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200804/1209121.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Prekliniska data presenterade för Active Biotechs ANYARA-teknologi]]></title>
<pubDate>Tue, 15 Apr 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200804/1209111.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation to Annual General Meeting of Shareholders]]></title>
<pubDate>Wed, 9 Apr 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200804/1207601.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Kallelse till årsstämma]]></title>
<pubDate>Wed, 9 Apr 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200804/1207595.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[The Board of Active Biotech AB proposes that the Annual General Meeting resolve to make a guaranteed rights issue of approximately SEK 160 M]]></title>
<pubDate>Mon, 7 Apr 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200804/1206867.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Styrelsen för Active Biotech AB föreslår årsstämman att besluta om en garanterad företrädesemission om cirka 160 MSEK]]></title>
<pubDate>Mon, 7 Apr 2008 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200804/1206864.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Year-End Report January-December 2007]]></title>
<pubDate>Thu, 14 Feb 2008 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200802/1191559.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Bokslutsrapport januari-december 2007]]></title>
<pubDate>Thu, 14 Feb 2008 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200802/1191550.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's election committee appointed ]]></title>
<pubDate>Thu, 22 Nov 2007 10:17:44 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200711/1170208.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs valberedning utsedd            ]]></title>
<pubDate>Thu, 22 Nov 2007 10:13:38 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200711/1170205.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Interim Report Jan-Sep 2007]]></title>
<pubDate>Thu, 8 Nov 2007 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200711/1166898.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Delårsrapport jan-sep 2007]]></title>
<pubDate>Thu, 8 Nov 2007 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200711/1166897.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation Conference Call - Active Biotech AB]]></title>
<pubDate>Wed, 7 Nov 2007 09:23:30 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200711/1166626.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Inbjudan Telekonferens - Active Biotech AB]]></title>
<pubDate>Wed, 7 Nov 2007 09:18:57 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200711/1166622.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[INITIATION OF ENROLLMENT IN PIVOTAL PHASE III CLINICAL STUDY OF ORAL LAQUINIMOD FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS]]></title>
<pubDate>Wed, 7 Nov 2007 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200711/1166589.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[PATIENTREKRYTERING TILL REGISTRERINGSGRUNDANDE KLINISK FAS III-STUDIE INLEDD FÖR ORALT LAQUINIMOD FÖR BEHANDLING AV RELAPSERANDE REMITTERANDE MULTIPEL SKLEROS]]></title>
<pubDate>Wed, 7 Nov 2007 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200711/1166576.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at the Rodman & Renshaw 9th Annual Healthcare Conference ]]></title>
<pubDate>Thu, 1 Nov 2007 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200711/1161585.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at the Rodman & Renshaw 9th Annual Healthcare Conference ]]></title>
<pubDate>Thu, 1 Nov 2007 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200711/1161576.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's Cancer Project ANYARA Proven Safe in Combination with Taxotere®]]></title>
<pubDate>Wed, 24 Oct 2007 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200710/1161567.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs cancerprojekt ANYARA säkert i kombination med Taxotere®]]></title>
<pubDate>Wed, 24 Oct 2007 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200710/1161553.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[RhuDex®; MediGene Obtains US Patent]]></title>
<pubDate>Tue, 2 Oct 2007 13:59:35 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200710/1157539.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[RhuDex®; MediGene erhåller patent i USA]]></title>
<pubDate>Tue, 2 Oct 2007 13:54:40 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200710/1157534.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at the UBS 2007 Global Life Sciences Conference ]]></title>
<pubDate>Thu, 20 Sep 2007 09:18:44 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200709/1154880.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[FDA Approves IND for Phase II Studies of TASQ ]]></title>
<pubDate>Fri, 10 Aug 2007 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200708/1145578.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[FDA godkänner IND för start av TASQ fas II-studier]]></title>
<pubDate>Fri, 10 Aug 2007 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200708/1145576.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Interim Report January-June 2007]]></title>
<pubDate>Thu, 9 Aug 2007 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200708/1145070.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Delårsrapport januari-juni 2007]]></title>
<pubDate>Thu, 9 Aug 2007 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200708/1145066.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[EMEA Grants Orphan Drug Status to Active Biotech's Cancer Treatment ANYARA]]></title>
<pubDate>Thu, 26 Jul 2007 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200707/1142053.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs cancerläkemedel ANYARA erhåller orphan drug-status av EMEA ]]></title>
<pubDate>Thu, 26 Jul 2007 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200707/1142050.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presents new pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation]]></title>
<pubDate>Mon, 18 Jun 2007 11:45:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200706/1133614.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presenterar nya prekliniska data för 57-57 på "8th World Congress on Inflammation"]]></title>
<pubDate>Mon, 18 Jun 2007 11:45:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200706/1133604.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[New positive pre-clinical data for Active Biotech's RA project I-3D]]></title>
<pubDate>Fri, 15 Jun 2007 11:45:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200706/1133140.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Nya positiva prekliniska data för Active Biotechs RA-projekt I-3D]]></title>
<pubDate>Fri, 15 Jun 2007 11:45:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200706/1133138.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[TEVA AND ACTIVE BIOTECH TO INITIATE PIVOTAL PHASE III TRIAL PROGRAM OF ORAL LAQUINIMOD FOR RELAPSING MULTIPLE SCLEROSIS]]></title>
<pubDate>Thu, 7 Jun 2007 08:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200706/1131616.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[ACTIVE BIOTECH OCH TEVA INLEDER REGISTRERINGSGRUNDANDE FAS III-PRÖVNINGAR AV SITT ORALA MS-PREPARAT LAQUINIMOD ]]></title>
<pubDate>Thu, 7 Jun 2007 08:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200706/1131615.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at the Rodman & Renshaw 4th Annual Global Healthcare Conference]]></title>
<pubDate>Thu, 10 May 2007 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200705/1124218.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Interim Report Jan-March 2007]]></title>
<pubDate>Fri, 4 May 2007 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200705/1124090.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Delårsrapport januari-mars 2007]]></title>
<pubDate>Fri, 4 May 2007 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200705/1124088.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at BIO 2007 Annual International Convention]]></title>
<pubDate>Thu, 3 May 2007 10:05:27 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200705/1123785.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Laquinimod, a Novel Oral Compound, Showed Significant Reduction in Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS)]]></title>
<pubDate>Tue, 1 May 2007 20:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200705/1123242.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Laquinimod, en ny substans i tablettform, uppvisar en signifikant minskning av sjukdomsaktiviteten i patienter med relapserande remitterande multipel skleros (RRMS)]]></title>
<pubDate>Tue, 1 May 2007 20:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200705/1123239.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Annual General Meeting of Active Biotech AB ]]></title>
<pubDate>Fri, 20 Apr 2007 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200704/1120178.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Årsstämma i Active Biotech AB]]></title>
<pubDate>Fri, 20 Apr 2007 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200704/1120174.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Early repayment of Active Biotech's convertible loan ]]></title>
<pubDate>Wed, 28 Mar 2007 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200703/1114955.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Förtida lösen av Active Biotechs konvertibellån]]></title>
<pubDate>Wed, 28 Mar 2007 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200703/1114953.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Publishes Data Regarding the TASQ Prostate Cancer Project ]]></title>
<pubDate>Tue, 27 Mar 2007 13:36:49 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200703/1114760.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech publicerar data gällande prostatacancerprojektet TASQ]]></title>
<pubDate>Tue, 27 Mar 2007 13:27:51 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200703/1114752.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation to Annual General Meeting of Shareholders]]></title>
<pubDate>Thu, 22 Mar 2007 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200703/1113321.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Kallelse till årsstämma]]></title>
<pubDate>Thu, 22 Mar 2007 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200703/1113309.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[The Election Committee's proposal for approval by the Annual General Meeting of Active Biotech]]></title>
<pubDate>Thu, 15 Mar 2007 11:43:16 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200703/1112109.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Valberedningens förslag till beslut på Active Biotechs årsstämma]]></title>
<pubDate>Thu, 15 Mar 2007 11:36:44 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200703/1112105.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's I-3D micro-dosing clinical trial concluded]]></title>
<pubDate>Tue, 13 Mar 2007 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200703/1111203.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs I-3D klinisk mikrodos-studie avslutad]]></title>
<pubDate>Tue, 13 Mar 2007 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200703/1111200.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Positive Clinical Data for TASQ - Active Biotech's Novel Treatment of  Prostate Cancer]]></title>
<pubDate>Fri, 9 Mar 2007 13:23:51 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200703/1110875.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Positiva kliniska data för TASQ - Active Biotechs projekt för behandling av prostatacancer]]></title>
<pubDate>Fri, 9 Mar 2007 13:19:01 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200703/1110857.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech påkallar förtida återbetalning av konvertibellån]]></title>
<pubDate>Thu, 15 Feb 2007 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200702/1105243.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech calls for premature repayment of convertible loan]]></title>
<pubDate>Thu, 15 Feb 2007 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200702/1105242.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Year-End Report 2006]]></title>
<pubDate>Thu, 15 Feb 2007 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200702/1105240.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Bokslutsrapport 2006]]></title>
<pubDate>Thu, 15 Feb 2007 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200702/1105236.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's new share issue oversubscribed]]></title>
<pubDate>Wed, 14 Feb 2007 13:26:31 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200702/1105164.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs nyemission övertecknad]]></title>
<pubDate>Wed, 14 Feb 2007 13:21:07 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200702/1105157.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[RhuDex® Enters Clinical Phase IIa Trial in Rheumatoid Arthritis]]></title>
<pubDate>Tue, 23 Jan 2007 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200701/1099416.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[RhuDex® inleder kliniska fas II-prövningar för behandling av ledgångsreumatism]]></title>
<pubDate>Tue, 23 Jan 2007 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200701/1099415.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's nominations committee appointed    ]]></title>
<pubDate>Fri, 12 Jan 2007 10:32:14 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200701/1097893.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs nomineringskommitté utsedd   ]]></title>
<pubDate>Fri, 12 Jan 2007 10:28:17 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200701/1097891.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs garanterade företrädesemission om 240 MSEK; Korrigering]]></title>
<pubDate>Thu, 4 Jan 2007 11:45:24 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200701/1096542.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's Guaranteed Preferential Rights Issue of SEK 240 M; Correction]]></title>
<pubDate>Thu, 4 Jan 2007 11:41:20 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200701/1096544.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to conduct guaranteed preferential rights issue for approximately SEK 240 M]]></title>
<pubDate>Mon, 18 Dec 2006 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200612/1093759.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech genomför garanterad företrädesemission om cirka 240 MSEK ]]></title>
<pubDate>Mon, 18 Dec 2006 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200612/1093758.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs nya cancerbehandling ANYARA uppvisar farmakologisk effekt i patienter i framgångsrika fas I-studier]]></title>
<pubDate>Wed, 13 Dec 2006 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200612/1092920.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's Novel Cancer Treatment ANYARA Shows Pharmacological Proof of Concept after Successful Phase I Studies]]></title>
<pubDate>Wed, 13 Dec 2006 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200612/1092917.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech receives 5 MSEK from VINNOVA]]></title>
<pubDate>Tue, 21 Nov 2006 15:45:27 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200611/1089455.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech erhåller 5 miljoner kronor från VINNOVA]]></title>
<pubDate>Tue, 21 Nov 2006 15:42:36 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200611/1089453.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Interim Report Jan-Sep 2006]]></title>
<pubDate>Thu, 2 Nov 2006 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200611/1085590.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Delårsrapport Jan-Sept 2006]]></title>
<pubDate>Thu, 2 Nov 2006 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200611/1085585.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at the Rodman & Renshaw 8th Annual Healthcare Conference ]]></title>
<pubDate>Wed, 1 Nov 2006 13:49:32 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200611/1085340.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Maria Borelius leaves the Board of Active Biotech AB]]></title>
<pubDate>Mon, 9 Oct 2006 08:50:52 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200610/1080009.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Maria Borelius lämnar styrelsen i Active Biotech AB ]]></title>
<pubDate>Mon, 9 Oct 2006 08:47:07 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200610/1080006.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Positive clinical results for Active Biotech's prostate cancer project TASQ   ]]></title>
<pubDate>Wed, 20 Sep 2006 13:01:38 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200609/1076793.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Positiva kliniska resultat för Active Biotechs prostatacancerprojekt TASQ  ]]></title>
<pubDate>Wed, 20 Sep 2006 13:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200609/1076785.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at the UBS Global Life Sciences Conference ]]></title>
<pubDate>Mon, 18 Sep 2006 09:24:27 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200609/1075767.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech publishes pre-clinical data regarding the TASQ prostate cancer project ]]></title>
<pubDate>Thu, 7 Sep 2006 16:08:49 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200609/1074243.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech publicerar prekliniska data gällande prostatacancerprojektet TASQ   ]]></title>
<pubDate>Thu, 7 Sep 2006 16:07:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200609/1074240.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Fas IIb-studie bekräftar laquinimods effektivitet och fördelaktiga säkerhetsprofil samt uppvisar en signifikant minskning av inflammatorisk sjukdomsaktivitet]]></title>
<pubDate>Tue, 5 Sep 2006 16:41:58 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200609/1073567.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Laquinimod Phase IIb Trial confirms efficacy and favorable safety profile and shows significant reduction in the rate of inflammatory disease activity]]></title>
<pubDate>Tue, 5 Sep 2006 16:40:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200609/1073561.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Interim Report January-June 2006]]></title>
<pubDate>Thu, 10 Aug 2006 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200608/1068366.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Delårsrapport Januari-Juni 2006]]></title>
<pubDate>Thu, 10 Aug 2006 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200608/1068363.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation Conference Call - Active Biotech AB]]></title>
<pubDate>Tue, 8 Aug 2006 09:14:54 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200608/1067809.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Inbjudan Telekonferens - Active Biotech AB]]></title>
<pubDate>Tue, 8 Aug 2006 09:10:25 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200608/1067804.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's project 57-57 presented at EULAR in Amsterdam]]></title>
<pubDate>Mon, 26 Jun 2006 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200606/1059479.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs projekt 57-57 presenterat på EULAR i Amsterdam]]></title>
<pubDate>Mon, 26 Jun 2006 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200606/1059466.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's ANYARA cancer project presented at ASCO in Atlanta]]></title>
<pubDate>Mon, 5 Jun 2006 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200606/1054008.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs cancerprojekt ANYARA presenterat på ASCO i Atlanta]]></title>
<pubDate>Mon, 5 Jun 2006 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200606/1054007.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at the Rodman & Renshaw]]></title>
<pubDate>Fri, 12 May 2006 09:17:53 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200605/1050831.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Interim Report January-March 2006]]></title>
<pubDate>Thu, 11 May 2006 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200605/1050463.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Delårsrapport januari-mars 2006]]></title>
<pubDate>Thu, 11 May 2006 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200605/1050458.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[ACTIVE BIOTECH AND CHELSEA THERAPEUTICS TO CO-DEVELOP PORTFOLIO]]></title>
<pubDate>Tue, 9 May 2006 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200605/1049929.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[ACTIVE BIOTECH OCH CHELSEA THERAPEUTICS TECKNAR SAMARBETSAVTAL]]></title>
<pubDate>Tue, 9 May 2006 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200605/1049926.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation Conference Call - Active Biotech AB]]></title>
<pubDate>Mon, 8 May 2006 10:27:27 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200605/1049580.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Inbjudan Telekonferens - Active Biotech AB]]></title>
<pubDate>Mon, 8 May 2006 10:24:22 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200605/1049578.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Annual General Meeting of Active Biotech AB]]></title>
<pubDate>Thu, 27 Apr 2006 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200604/1047257.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Bolagsstämma i Active Biotech AB]]></title>
<pubDate>Thu, 27 Apr 2006 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200604/1047256.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech at BIO 2006]]></title>
<pubDate>Tue, 4 Apr 2006 10:31:39 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200604/1043137.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation to Annual General Meeting of Shareholders]]></title>
<pubDate>Tue, 28 Mar 2006 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200603/1041405.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Kallelse till årsstämma]]></title>
<pubDate>Tue, 28 Mar 2006 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200603/1041398.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Patent application submitted regarding the mode of action for quinoline compounds]]></title>
<pubDate>Mon, 27 Mar 2006 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200603/1041277.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Patentansökan inskickad rörande quinolinsubstansernas verkningsmekanism]]></title>
<pubDate>Mon, 27 Mar 2006 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200603/1041274.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[RhuDex® successfully concludes Phase I clinical trials]]></title>
<pubDate>Thu, 9 Mar 2006 10:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200603/1038427.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[RhuDex® avslutar fas I-studier positivt]]></title>
<pubDate>Thu, 9 Mar 2006 10:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200603/1038422.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at the Cowen & Company 26th Annual Health Care Conference]]></title>
<pubDate>Mon, 6 Mar 2006 09:51:38 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200603/1037854.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Year-end Report January-December 2005]]></title>
<pubDate>Thu, 16 Feb 2006 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200602/1035142.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Bokslutsrapport januari-december 2005]]></title>
<pubDate>Thu, 16 Feb 2006 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200602/1035140.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation Teleconference - Active Biotech AB]]></title>
<pubDate>Mon, 13 Feb 2006 10:55:03 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200602/1034392.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Inbjudan Telekonferens - Active Biotech AB]]></title>
<pubDate>Mon, 13 Feb 2006 10:51:57 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200602/1034388.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's nominations committee appointed]]></title>
<pubDate>Mon, 16 Jan 2006 08:48:15 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200601/1029968.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs nomineringskommitté utsedd]]></title>
<pubDate>Mon, 16 Jan 2006 08:36:27 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200601/1029961.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Advances 57-57 Project]]></title>
<pubDate>Mon, 19 Dec 2005 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200512/1025993.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech har startat klinisk prövning med patienter för projektet 57-57]]></title>
<pubDate>Mon, 19 Dec 2005 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200512/1025991.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Reports Interim Results of ANYARA Phase I Clinical Trial]]></title>
<pubDate>Thu, 15 Dec 2005 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200512/1025566.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech rapporterar interimsresultat från ANYARA fas I klinisk studie]]></title>
<pubDate>Thu, 15 Dec 2005 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200512/1025561.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Commences Clinical Phase I Combination Study of ANYARA and Taxotere®]]></title>
<pubDate>Tue, 8 Nov 2005 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200511/1019891.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech inleder klinisk fas I kombinationsstudie med ANYARA och Taxotere®]]></title>
<pubDate>Tue, 8 Nov 2005 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200511/1019888.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at the SG Cowen & Company 6th Annual]]></title>
<pubDate>Thu, 3 Nov 2005 09:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200511/1019096.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Interim Report January - September 2005]]></title>
<pubDate>Wed, 2 Nov 2005 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200511/1019179.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Delårsrapport Januari-September 2005]]></title>
<pubDate>Wed, 2 Nov 2005 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200511/1019176.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to Present at The Rodman & Renshaw Techvest]]></title>
<pubDate>Tue, 1 Nov 2005 14:54:47 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200511/1019090.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation Teleconference - Active Biotech AB]]></title>
<pubDate>Fri, 28 Oct 2005 09:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200510/1018333.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Inbjudan Telekonferens - Active Biotech AB]]></title>
<pubDate>Fri, 28 Oct 2005 09:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200510/1018332.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presents survival data on cancer drug]]></title>
<pubDate>Fri, 30 Sep 2005 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200509/1013727.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presenterar överlevnadsdata för cancerläkemedel]]></title>
<pubDate>Fri, 30 Sep 2005 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200509/1013726.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Confirmed ANYARA tumor PET localization in cancer patients]]></title>
<pubDate>Fri, 30 Sep 2005 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200509/1013724.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Bekräftad tumörlokalisation av ANYARA hos cancerpatienter med hjälp av PET]]></title>
<pubDate>Fri, 30 Sep 2005 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200509/1013722.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presents survival data on cancer drug]]></title>
<pubDate>Thu, 29 Sep 2005 21:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200509/1013721.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presenterar överlevnadsdata för cancerläkemedel]]></title>
<pubDate>Thu, 29 Sep 2005 21:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200509/1013720.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Confirmed ANYARA tumor PET localization in cancer patients]]></title>
<pubDate>Thu, 29 Sep 2005 21:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200509/1013719.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Bekräftad tumörlokalisation av ANYARA hos cancerpatienter med hjälp av PET]]></title>
<pubDate>Thu, 29 Sep 2005 21:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200509/1013718.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Confirmed favorable safety profile for Active Biotech's oral MS drug]]></title>
<pubDate>Tue, 27 Sep 2005 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200509/1013232.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Fördelaktig säkerhetsprofil bekräftad för Active Biotechs orala MS-läkemedel]]></title>
<pubDate>Tue, 27 Sep 2005 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200509/1013229.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to present at UBS Global Life Sciences Conference]]></title>
<pubDate>Thu, 22 Sep 2005 14:21:47 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200509/1012869.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Interim report January - June 2005]]></title>
<pubDate>Thu, 11 Aug 2005 09:13:07 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200508/1005802.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB Delårsrapport Januari-juni 2005]]></title>
<pubDate>Thu, 11 Aug 2005 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200508/1005707.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation Teleconference - Active Biotech AB]]></title>
<pubDate>Tue, 9 Aug 2005 09:32:18 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200508/1005381.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Inbjudan Telekonferens - Active Biotech AB]]></title>
<pubDate>Tue, 9 Aug 2005 09:25:12 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200508/1005379.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Phase I study for Active Biotech's SLE project 57-57  successfully concluded]]></title>
<pubDate>Mon, 18 Jul 2005 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200507/1002649.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Fas I-studie positivt avslutad för Active Biotechs SLE-projekt 57-57]]></title>
<pubDate>Mon, 18 Jul 2005 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200507/1002648.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's new share issue oversubscribed]]></title>
<pubDate>Thu, 7 Jul 2005 11:15:02 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200507/1001667.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs nyemission övertecknad]]></title>
<pubDate>Thu, 7 Jul 2005 11:02:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200507/1001666.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[TEVA AND ACTIVE BIOTECH ANNOUNCE THE SUBMISSION OF AN IND TO THE FDA FOR LAQUINIMOD, AN ORAL PRODUCT FOR THE TREATMENT OF RELAPSING MS]]></title>
<pubDate>Tue, 28 Jun 2005 13:05:58 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200506/1000416.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[TEVA OCH ACTIVE BIOTECH LÄMNAR IN IND-ANSÖKAN TILL FDA FÖR LAQUINIMOD; EN ORAL PRODUKT FÖR BEHANDLING AV RELAPSERANDE MS]]></title>
<pubDate>Tue, 28 Jun 2005 13:01:52 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200506/1000415.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Meet Active Biotech at BIO2005 Annual Convention, June 19-22 in Philadelphia, USA]]></title>
<pubDate>Wed, 15 Jun 2005 09:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200506/998536.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's preferential rights issue for approximately 169 MSEK]]></title>
<pubDate>Wed, 18 May 2005 08:36:34 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200505/994760.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs företrädesemission om cirka 169 MSEK]]></title>
<pubDate>Wed, 18 May 2005 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200505/994752.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Interim Report  January-March 2005]]></title>
<pubDate>Thu, 12 May 2005 09:14:24 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200505/994087.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Delårsrapport januari-mars 2005]]></title>
<pubDate>Thu, 12 May 2005 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200505/994058.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation Teleconference - Active Biotech AB]]></title>
<pubDate>Mon, 9 May 2005 13:15:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200505/993327.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Inbjudan Telekonferens - Active Biotech AB]]></title>
<pubDate>Mon, 9 May 2005 13:15:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200505/993326.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[RhuDex® for the treatment of RA enters Phase I clinical trials]]></title>
<pubDate>Mon, 9 May 2005 11:45:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200505/993325.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[RhuDex för behandling av RA inleder fas I kliniska prövningar]]></title>
<pubDate>Mon, 9 May 2005 11:45:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200505/993323.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to present at Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference]]></title>
<pubDate>Fri, 29 Apr 2005 09:37:31 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200504/992045.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presenterar på Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference]]></title>
<pubDate>Fri, 29 Apr 2005 09:33:23 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200504/992044.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[VDs anförande vid Active Biotechs bolagsstämma 2005]]></title>
<pubDate>Fri, 22 Apr 2005 09:21:11 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200504/990519.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Bolagsstämma i Active Biotech AB]]></title>
<pubDate>Fri, 22 Apr 2005 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200504/990475.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Annual General Meeting of Active Biotech AB]]></title>
<pubDate>Fri, 22 Apr 2005 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200504/990472.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation to Annual General Meeting of Shareholders]]></title>
<pubDate>Thu, 24 Mar 2005 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200503/986336.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Kallelse till bolagsstämma]]></title>
<pubDate>Thu, 24 Mar 2005 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200503/986333.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Teva and Active Biotech Announce That Laquinimod Phase II Data Has Been Published Today in Neurology]]></title>
<pubDate>Tue, 22 Mar 2005 13:16:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200503/986158.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Teva och Active Biotech meddelar att laquinimod fas II-data har publicerats idag i Neurology]]></title>
<pubDate>Tue, 22 Mar 2005 13:15:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200503/986147.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to present at SG Cowen & Co. 25th Annual Health Care Conference]]></title>
<pubDate>Thu, 10 Mar 2005 16:20:34 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200503/984414.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presenterar på SG Cowen & Co. 25th Annual Health Care Conference]]></title>
<pubDate>Thu, 10 Mar 2005 16:17:48 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200503/984413.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Year-end report Jan-Dec 2004]]></title>
<pubDate>Thu, 17 Feb 2005 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200502/981157.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Bokslutsrapport jan-dec 2004]]></title>
<pubDate>Thu, 17 Feb 2005 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200502/981154.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation Teleconference - Active Biotech AB]]></title>
<pubDate>Mon, 14 Feb 2005 13:08:49 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200502/980462.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Inbjudan Telekonferens - Active Biotech AB]]></title>
<pubDate>Mon, 14 Feb 2005 12:53:03 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200502/980461.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Shareholder-friendly measures to promote liquidity]]></title>
<pubDate>Thu, 3 Feb 2005 14:37:17 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200502/978888.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Likviditetsfrämjande och aktieägarvänliga åtgärder]]></title>
<pubDate>Thu, 3 Feb 2005 14:30:06 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200502/978884.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's nominations committee appointed]]></title>
<pubDate>Mon, 20 Dec 2004 14:01:31 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200412/972946.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs nomineringskommitté utsedd]]></title>
<pubDate>Mon, 20 Dec 2004 13:57:46 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200412/972944.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Convertible debentures issue fully subscribed]]></title>
<pubDate>Wed, 15 Dec 2004 08:31:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200412/972242.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Emissionen av konvertibla förlagsbevis i Active Biotech fulltecknad]]></title>
<pubDate>Wed, 15 Dec 2004 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200412/972243.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech commences clinical studies in prostate cancer patients]]></title>
<pubDate>Mon, 13 Dec 2004 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200412/971946.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech inleder kliniska studier i patienter med prostatacancer]]></title>
<pubDate>Mon, 13 Dec 2004 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200412/971945.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Approved patent in the U.S. for Active Biotech's cancer project TTS]]></title>
<pubDate>Thu, 2 Dec 2004 12:08:06 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200412/971134.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Godkänt patent i USA för Active Biotechs cancerprojekt TTS]]></title>
<pubDate>Thu, 2 Dec 2004 11:59:59 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200412/971133.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[FDA has granted Fast Track Status to Active Biotech's TTS cancer project]]></title>
<pubDate>Wed, 1 Dec 2004 10:38:32 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200412/970920.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[FDA har beviljat Fast Track-status för Active Biotechs cancerprojekt TTS]]></title>
<pubDate>Wed, 1 Dec 2004 10:28:29 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200412/970913.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to present at SG Cowen & Co 5th Annual Global Health Care Conference]]></title>
<pubDate>Mon, 15 Nov 2004 11:43:59 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200411/969102.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech presenterar på SG Cowen & Co 5th Annual Global Health Care Conference]]></title>
<pubDate>Mon, 15 Nov 2004 11:36:55 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200411/969097.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Extraordinary General Meeting - Active Biotech AB]]></title>
<pubDate>Tue, 9 Nov 2004 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200411/968097.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Extra bolagsstämma - Active Biotech AB]]></title>
<pubDate>Tue, 9 Nov 2004 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200411/968096.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Interim Report January-September 2004]]></title>
<pubDate>Fri, 5 Nov 2004 08:31:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200411/967610.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Delårsrapport januari-september 2004]]></title>
<pubDate>Fri, 5 Nov 2004 08:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200411/967607.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation Teleconference - Active Biotech AB]]></title>
<pubDate>Wed, 3 Nov 2004 09:18:19 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200411/967184.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Inbjudan Telekonferens - Active Biotech AB]]></title>
<pubDate>Wed, 3 Nov 2004 09:14:37 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200411/967182.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech commences clinical studies for 57-57 project against SLE]]></title>
<pubDate>Tue, 2 Nov 2004 14:36:29 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200411/967037.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech inleder kliniska studier för projekt 57-57 för SLE]]></title>
<pubDate>Tue, 2 Nov 2004 14:31:16 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200411/967035.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference]]></title>
<pubDate>Mon, 25 Oct 2004 13:52:42 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200410/965531.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Announcement of debenture issue]]></title>
<pubDate>Fri, 22 Oct 2004 08:03:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200410/965199.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Kungörelse av emissionsbeslut]]></title>
<pubDate>Fri, 22 Oct 2004 08:02:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200410/965202.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation to Extraordinary General Meeting of Shareholders]]></title>
<pubDate>Fri, 22 Oct 2004 08:01:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200410/965193.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Kallelse till extra bolagsstämma]]></title>
<pubDate>Fri, 22 Oct 2004 08:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200410/965191.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's Capital Market Meeting with Teva Pharmaceutical Industries in Stockholm on October 19]]></title>
<pubDate>Mon, 18 Oct 2004 11:02:17 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200410/964507.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs kapitalmarknadsmöte med Teva Pharmaceutical Industries i Stockholm den 19 oktober]]></title>
<pubDate>Mon, 18 Oct 2004 10:57:49 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200410/964504.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to present at UBS Global Life Sciences Conference]]></title>
<pubDate>Wed, 22 Sep 2004 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200409/961423.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation to Active Biotech's capital market meeting with Teva Pharmaceutical Industries in Stockholm on October 19]]></title>
<pubDate>Wed, 15 Sep 2004 16:46:38 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200409/960749.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Inbjudan till Active Biotechs kapitalmarknadsmöte med Teva Pharmaceutical Industries i Stockholm den 19 oktober]]></title>
<pubDate>Wed, 15 Sep 2004 16:45:30 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200409/960746.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech proposes a rights issue of convertible debentures totalling SEK 150 M]]></title>
<pubDate>Wed, 15 Sep 2004 16:37:57 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200409/960745.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech föreslår nyemission av konvertibler om cirka 150 Mkr]]></title>
<pubDate>Wed, 15 Sep 2004 16:35:32 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200409/960741.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Correction of information in the magazine Affärsvärlden]]></title>
<pubDate>Wed, 25 Aug 2004 14:26:44 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200408/958106.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Rättelse av uppgifter i tidningen Affärsvärlden]]></title>
<pubDate>Wed, 25 Aug 2004 14:22:46 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200408/958103.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[FEDERAL TRADE COMMISSION CLEARS TEVA/ACTIVE BIOTECH AGREEMENT]]></title>
<pubDate>Tue, 24 Aug 2004 14:23:21 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200408/957893.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[FEDERAL TRADE COMMISSION GODKÄNNER AVTAL MELLAN  TEVA OCH ACTIVE BIOTECH]]></title>
<pubDate>Tue, 24 Aug 2004 14:19:58 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200408/957887.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech - Interim report Jan-Jun 2004]]></title>
<pubDate>Thu, 12 Aug 2004 10:06:02 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200408/955558.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech - Delårsrapport januari-juni 2004]]></title>
<pubDate>Thu, 12 Aug 2004 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200408/955426.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation Teleconference - Active Biotech AB]]></title>
<pubDate>Mon, 9 Aug 2004 10:40:18 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200408/954958.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Inbjudan Telekonferens - Active Biotech AB]]></title>
<pubDate>Mon, 9 Aug 2004 10:36:06 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200408/954957.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[TEVA AND ACTIVE BIOTECH ANNOUNCE AGREEMENT FOR LAQUINIMOD]]></title>
<pubDate>Mon, 14 Jun 2004 08:49:26 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200406/948906.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[TEVA OCH ACTIVE BIOTECH SLUTER AVTAL KRING LAQUINIMOD FÖR ORAL BEHANDLING AV MULTIPEL SKLEROS]]></title>
<pubDate>Mon, 14 Jun 2004 08:46:02 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200406/948903.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB and Strathmann Biotec AG conclude agreement regarding manufacturing of TTS cancer product]]></title>
<pubDate>Thu, 3 Jun 2004 09:05:47 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200406/947941.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB och Strathmann Biotec AG tecknar avtal för produktion av cancerprodukten TTS]]></title>
<pubDate>Thu, 3 Jun 2004 09:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200406/947939.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Meet Active Biotech at BIO2004 Annual Convention, June 6-9 in San Francisco, CA]]></title>
<pubDate>Wed, 2 Jun 2004 15:00:16 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200406/947888.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Avidex and Active Biotech enter collaboration to develop fusion proteins combining monoclonal mTCRs with superantigens]]></title>
<pubDate>Thu, 13 May 2004 08:33:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200405/945473.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech tecknar samarbetsavtal med Avidex Ltd för utveckling av fusionsprotein med monoklonala TCR och superantigen]]></title>
<pubDate>Thu, 13 May 2004 08:32:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200405/945470.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Interim Report January-March 2004]]></title>
<pubDate>Thu, 13 May 2004 08:31:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200405/945469.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Delårsrapport januari-mars 2004]]></title>
<pubDate>Thu, 13 May 2004 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200405/945467.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation Teleconference - Active Biotech AB]]></title>
<pubDate>Tue, 11 May 2004 09:39:52 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200405/945137.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Inbjudan Telekonferens - Active Biotech AB]]></title>
<pubDate>Tue, 11 May 2004 09:38:30 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200405/945133.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech at the 56th Annual Meeting of the American Academy of Neurology]]></title>
<pubDate>Tue, 27 Apr 2004 09:15:42 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200404/942799.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech vid 56th Annual Meeting of the American Academy of Neurology]]></title>
<pubDate>Tue, 27 Apr 2004 09:09:27 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200404/942795.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Annual General Meeting of Active Biotech AB]]></title>
<pubDate>Thu, 22 Apr 2004 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200404/942291.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Bolagsstämma i Active Biotech AB]]></title>
<pubDate>Thu, 22 Apr 2004 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200404/942287.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech - Annual Report 2003]]></title>
<pubDate>Fri, 2 Apr 2004 13:34:53 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200404/940541.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech - Årsredovisning 2003]]></title>
<pubDate>Fri, 2 Apr 2004 13:32:18 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200404/940533.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech and PowderJect Pharmaceuticals have reached an amicable settlement of their arbitration]]></title>
<pubDate>Thu, 1 Apr 2004 16:48:16 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200404/940411.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech och Chiron har enats om en förlikning i skiljedomsförfarandet]]></title>
<pubDate>Thu, 1 Apr 2004 16:37:04 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200404/940397.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Pancreatic cancer suitable for treatment with Active Biotech's TTS cancer products]]></title>
<pubDate>Thu, 25 Mar 2004 09:34:07 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200403/939424.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs cancerprodukt TTS verksam för behandling av pankreascancer]]></title>
<pubDate>Thu, 25 Mar 2004 09:27:37 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200403/939422.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation to Annual General Meeting of Shareholders]]></title>
<pubDate>Wed, 24 Mar 2004 09:20:20 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200403/939212.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Kallelse till bolagsstämma]]></title>
<pubDate>Wed, 24 Mar 2004 09:17:34 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200403/939206.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech focuses operations on development projects]]></title>
<pubDate>Fri, 27 Feb 2004 09:26:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200402/936104.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech fokuserar verksamheten mot projekt i klinisk fas]]></title>
<pubDate>Fri, 27 Feb 2004 09:25:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200402/936102.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech - Year End Report, January-December 2003]]></title>
<pubDate>Thu, 12 Feb 2004 12:33:33 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200402/934161.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech - Bokslutsrapport, januari-december 2003]]></title>
<pubDate>Thu, 12 Feb 2004 09:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200402/934054.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation Teleconference - Active Biotech AB]]></title>
<pubDate>Mon, 9 Feb 2004 11:36:47 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200402/933453.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Inbjudan Telekonferens - Active Biotech AB]]></title>
<pubDate>Mon, 9 Feb 2004 11:34:54 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200402/933451.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Ingen relation till Biometron AB]]></title>
<pubDate>Thu, 15 Jan 2004 12:07:40 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200401/930815.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB on Attract 40]]></title>
<pubDate>Fri, 2 Jan 2004 12:12:36 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200401/929653.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech på Attract 40]]></title>
<pubDate>Fri, 2 Jan 2004 12:10:13 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200401/929652.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech - the first day for trading in the new single class of shares will be December 19]]></title>
<pubDate>Thu, 18 Dec 2003 10:39:50 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200312/928801.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech - handel med ett enda aktieslag inleds den 19 december]]></title>
<pubDate>Thu, 18 Dec 2003 10:34:18 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200312/928799.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Positive results confirmed in final report for Active Biotech's TTS cancer product]]></title>
<pubDate>Wed, 17 Dec 2003 07:31:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200312/928511.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Positiva resultat konfirmerade i slutrapport för Active Biotechs cancerprodukt TTS]]></title>
<pubDate>Wed, 17 Dec 2003 07:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200312/928510.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Decision by Extraordinary General Meeting of Active Biotech AB (publ)]]></title>
<pubDate>Mon, 8 Dec 2003 17:06:34 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200312/927603.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Beslut från extra bolagsstämma Active Biotech AB (publ)]]></title>
<pubDate>Mon, 8 Dec 2003 16:51:29 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200312/927602.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation to Extraordinary General Meeting of Shareholders]]></title>
<pubDate>Mon, 10 Nov 2003 09:09:16 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200311/924247.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Kallelse till extra bolagsstämma]]></title>
<pubDate>Mon, 10 Nov 2003 09:03:45 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200311/924242.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Interim Report January - September 2003]]></title>
<pubDate>Thu, 6 Nov 2003 08:00:44 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200311/923820.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Delårsrapport januari - september 2003]]></title>
<pubDate>Thu, 6 Nov 2003 07:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200311/923775.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Positive preclinical results for Active Biotech's project 57-57 for the treatment of SLE]]></title>
<pubDate>Mon, 27 Oct 2003 08:01:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200310/922057.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Positiva prekliniska resultat för Active Biotechs projekt 57-57 för behandling av SLE]]></title>
<pubDate>Mon, 27 Oct 2003 08:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200310/922055.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech to present at UBS Global Life Sciences Conference]]></title>
<pubDate>Wed, 17 Sep 2003 07:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200309/917604.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation Teleconference - Active Biotech AB]]></title>
<pubDate>Tue, 16 Sep 2003 07:36:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200309/917440.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Inbjudan Telekonferens - Active Biotech AB]]></title>
<pubDate>Tue, 16 Sep 2003 07:35:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200309/917439.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Primary endpoint reached in Phase II clinical trial of Active Biotech's substance for oral treatment of multiple sclerosis]]></title>
<pubDate>Tue, 16 Sep 2003 07:31:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200309/917436.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs orala substans för behandling av multipel skleros uppnår primärt mål i klinisk fas II-prövning]]></title>
<pubDate>Tue, 16 Sep 2003 07:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200309/917433.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Interim Report January-June 2003]]></title>
<pubDate>Thu, 14 Aug 2003 08:39:33 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200308/913746.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Delårsrapport Januari-Juni 2003]]></title>
<pubDate>Thu, 14 Aug 2003 08:32:53 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200308/913735.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation Teleconference - Active Biotech AB]]></title>
<pubDate>Mon, 11 Aug 2003 11:07:08 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200308/913197.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Inbjudan Telekonferens - Active Biotech AB]]></title>
<pubDate>Mon, 11 Aug 2003 11:04:19 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200308/913196.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[CPMP recommends registration for Dukoral in the EU]]></title>
<pubDate>Mon, 28 Jul 2003 09:00:42 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200307/911885.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[CPMP rekommenderar registrering i EU för Dukoral]]></title>
<pubDate>Fri, 25 Jul 2003 16:07:46 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200307/911855.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Meet Active Biotech at BIO2003 Annual Convention, June 22-25 in Washington D.C]]></title>
<pubDate>Wed, 18 Jun 2003 09:19:06 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200306/908291.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech rejects the claim made by PowderJect Pharmaceuticals]]></title>
<pubDate>Thu, 12 Jun 2003 14:04:01 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200306/907448.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech avvisar krav från PowderJect Pharmaceuticals]]></title>
<pubDate>Thu, 12 Jun 2003 14:01:46 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200306/907444.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[First day for trading in Active Biotech's newly issued B shares will be on Friday June 6, 2003]]></title>
<pubDate>Wed, 4 Jun 2003 08:41:34 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200306/906378.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Första dag för handel i Active Biotechs nyemitterade B-aktier blir fredagen den 6 juni 2003]]></title>
<pubDate>Wed, 4 Jun 2003 08:39:46 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200306/906373.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Interim evaluation of Active Biotech's TTS CD2 for renal cancer shows encouraging results in clinical Phase IIa]]></title>
<pubDate>Mon, 2 Jun 2003 10:00:44 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200306/905994.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Interimsutvärdering av Active Biotechs TTS CD2 mot njurcancer visar lovande resultat i klinisk Fas IIa]]></title>
<pubDate>Mon, 2 Jun 2003 09:56:53 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200306/905991.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Final count confirms Active Biotech's new share issue oversubscribed]]></title>
<pubDate>Fri, 23 May 2003 08:32:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200305/905172.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Slutlig sammanräkning bekräftar överteckning i Active Biotechs nyemission]]></title>
<pubDate>Fri, 23 May 2003 08:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200305/905169.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's new share issue oversubscribed]]></title>
<pubDate>Mon, 19 May 2003 17:36:40 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200305/904552.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs nyemission övertecknad]]></title>
<pubDate>Mon, 19 May 2003 15:54:52 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200305/904530.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Interim Report January-March 2003]]></title>
<pubDate>Thu, 15 May 2003 09:58:39 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200305/903989.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Delårsrapport januari-mars 2003]]></title>
<pubDate>Thu, 15 May 2003 08:41:45 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200305/903949.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation Teleconference - Active Biotech AB]]></title>
<pubDate>Mon, 12 May 2003 15:22:59 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200305/903372.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Inbjudan Telekonferens - Active Biotech AB]]></title>
<pubDate>Mon, 12 May 2003 15:20:49 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200305/903371.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Cancer-treatment substance TTS CD3 enters Phase I clinical trials in US]]></title>
<pubDate>Thu, 8 May 2003 09:13:28 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200305/902689.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Cancerpreparatet TTS CD3 i Fas I klinisk studie i USA]]></title>
<pubDate>Thu, 8 May 2003 08:36:06 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200305/902672.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Indications regarding prolonged survival with Active Biotech's TTS cancer drug]]></title>
<pubDate>Wed, 23 Apr 2003 14:53:16 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200304/900179.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Indikationer avseende förlängd överlevnad med Active Biotechs TTS- cancerpreparat]]></title>
<pubDate>Wed, 23 Apr 2003 08:16:35 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200304/900019.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Annual General Meeting of Active Biotech AB]]></title>
<pubDate>Fri, 11 Apr 2003 08:56:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200304/899114.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Bolagsstämma i Active Biotech AB]]></title>
<pubDate>Fri, 11 Apr 2003 08:55:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200304/899108.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation to Annual General Meeting of Shareholders]]></title>
<pubDate>Thu, 13 Mar 2003 11:00:51 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200303/895321.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Kallelse till bolagsstämma]]></title>
<pubDate>Thu, 13 Mar 2003 10:51:15 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200303/895310.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech - SEK 225 million (approx. € 25 million) rights issue]]></title>
<pubDate>Thu, 13 Feb 2003 09:03:30 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200302/891478.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Quarterly Report Oct-Dec, Full Year 2002]]></title>
<pubDate>Thu, 13 Feb 2003 09:00:02 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200302/891474.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech - Företrädesemission om 225 Mkr]]></title>
<pubDate>Thu, 13 Feb 2003 08:46:39 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200302/891465.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Kvartalsrapport, Okt-Dec 2002, samt helår]]></title>
<pubDate>Thu, 13 Feb 2003 08:40:59 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200302/891458.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation Teleconference - Active Biotech AB]]></title>
<pubDate>Mon, 10 Feb 2003 14:44:34 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200302/891014.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Inbjudan Telekonferens - Active Biotech AB]]></title>
<pubDate>Mon, 10 Feb 2003 14:42:20 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200302/891012.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Positive results from preliminary clinical studies of Active Biotech's prostate cancer drug]]></title>
<pubDate>Wed, 29 Jan 2003 11:20:26 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200301/889865.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Positiva resultat från inledande kliniska studier av Active Biotechs prostatacancer-preparat]]></title>
<pubDate>Wed, 29 Jan 2003 11:16:28 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200301/889863.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Håkan Åström leaves the Board of Active Biotech]]></title>
<pubDate>Wed, 15 Jan 2003 14:40:31 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200301/887992.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Håkan Åström lämnar styrelsen i Active Biotech]]></title>
<pubDate>Wed, 15 Jan 2003 14:37:50 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200301/887988.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Application approved by the FDA for start of TTS clinical programme]]></title>
<pubDate>Thu, 9 Jan 2003 09:05:07 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200301/887463.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Ansökan godkänd av FDA för start av kliniskt prövningsprogram för cancerprojektet TTS]]></title>
<pubDate>Thu, 9 Jan 2003 09:02:17 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200301/887461.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Interim Report July-September 2002]]></title>
<pubDate>Thu, 14 Nov 2002 09:35:35 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200211/881474.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Kvartalsrapport Juli-September 2002]]></title>
<pubDate>Wed, 13 Nov 2002 21:57:34 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200211/881438.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[New date for Active Biotech&#8217;s Q3 Teleconference]]></title>
<pubDate>Wed, 13 Nov 2002 09:14:27 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200211/881315.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Ny tid för Active Biotechs Q3 telefonkonferens]]></title>
<pubDate>Wed, 13 Nov 2002 09:02:03 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200211/881312.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Ändrat datum för Active Biotechs Q3-rapport]]></title>
<pubDate>Fri, 8 Nov 2002 08:43:33 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200211/880843.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation Teleconference - Active Biotech AB]]></title>
<pubDate>Mon, 4 Nov 2002 15:14:55 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200211/880119.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Inbjudan Telekonferens - Active Biotech AB]]></title>
<pubDate>Mon, 4 Nov 2002 15:09:36 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200211/880118.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[New results from Active Biotech&#8217;s SAIK-MS project]]></title>
<pubDate>Thu, 10 Oct 2002 13:01:39 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200210/876201.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Interim Report April-June 2002]]></title>
<pubDate>Thu, 15 Aug 2002 09:52:22 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200208/869987.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Kvartalsrapport April-juni 2002]]></title>
<pubDate>Thu, 15 Aug 2002 09:24:56 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200208/869970.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Teleconference - Active Biotech AB]]></title>
<pubDate>Mon, 12 Aug 2002 11:16:51 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200208/869479.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Telekonferens - Active Biotech AB]]></title>
<pubDate>Mon, 12 Aug 2002 11:12:08 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200208/869474.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech has selected a new Candidate Drug for the treatment of SLE]]></title>
<pubDate>Mon, 24 Jun 2002 11:38:33 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200206/864186.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech har valt läkemedelskandidat för SLE-projektet]]></title>
<pubDate>Mon, 24 Jun 2002 11:22:17 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200206/864163.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech&#8217;s drug for the treatment of Multiple Sclerosis]]></title>
<pubDate>Fri, 31 May 2002 14:11:11 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200205/861613.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs läkemedel mot multipel skleros]]></title>
<pubDate>Fri, 31 May 2002 14:09:19 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200205/861608.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB, Interim Report January-March 2002]]></title>
<pubDate>Thu, 16 May 2002 14:25:25 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200205/859656.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB, Kvartalsrapport januari-mars 2002]]></title>
<pubDate>Thu, 16 May 2002 09:00:51 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200205/859576.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Telefonkonferens, Q1]]></title>
<pubDate>Wed, 15 May 2002 09:38:44 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200205/859438.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Annual General Meeting of Shareholders in Active Biotech 18 April 2002]]></title>
<pubDate>Fri, 19 Apr 2002 09:47:55 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200204/856151.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Bolagsstämma i Active Biotech AB den 18 april 2002 ]]></title>
<pubDate>Fri, 19 Apr 2002 09:26:04 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200204/856150.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's Phase II study of SAIK-MS has started]]></title>
<pubDate>Thu, 11 Apr 2002 10:34:35 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200204/855010.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs Fas II-studie av SAIK-MS har inletts]]></title>
<pubDate>Thu, 11 Apr 2002 10:29:59 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200204/855007.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech och Avidex tecknar licensavtal ]]></title>
<pubDate>Thu, 4 Apr 2002 13:23:33 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200204/854361.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech and Avidex sign Licensing Agreement ]]></title>
<pubDate>Thu, 4 Apr 2002 13:17:21 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200204/854358.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's application to start Phase II pancreas cancer trial approved by UK authorities  ]]></title>
<pubDate>Wed, 6 Feb 2002 09:17:13 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200202/847466.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs ansökan godkänd av engelska myndigheter för start av Fas II pankreascancer studie ]]></title>
<pubDate>Wed, 6 Feb 2002 09:14:06 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200202/847463.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech obtains US patent for cancer product]]></title>
<pubDate>Mon, 4 Feb 2002 11:07:56 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200202/847062.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech får patent i USA för cancerprodukt]]></title>
<pubDate>Mon, 4 Feb 2002 11:05:03 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200202/847054.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech signs licensing agreement with Oxigene regarding benzamide IP]]></title>
<pubDate>Mon, 26 Nov 2001 09:10:36 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200111/841479.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech tecknar licensavtal med Oxigene kring benzamidpatent]]></title>
<pubDate>Mon, 26 Nov 2001 09:08:30 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200111/841478.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's application for TTS Phase II trial approved by UK authorities]]></title>
<pubDate>Tue, 13 Nov 2001 11:17:36 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200111/840232.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs ansökan om klinisk prövning Fas II godkänd av brittiska myndigheter]]></title>
<pubDate>Tue, 13 Nov 2001 11:14:04 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200111/840220.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Phase II clinical trial for Active Biotech's multiple sclerosis drug SAIK-MS ]]></title>
<pubDate>Thu, 25 Oct 2001 12:21:48 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200110/837782.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Fas II klinisk prövning för Active Biotechs läkemedel mot MS ]]></title>
<pubDate>Thu, 25 Oct 2001 12:20:04 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200110/837779.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech signs Letter of Intent with Avidex Ltd. ]]></title>
<pubDate>Mon, 6 Aug 2001 14:19:38 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200108/829579.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech tecknar nytt samarbetsavtal]]></title>
<pubDate>Mon, 6 Aug 2001 14:17:43 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200108/829578.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech sells SBL Vaccin to PowderJect Pharmaceuticals ]]></title>
<pubDate>Tue, 3 Jul 2001 08:20:51 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200107/826403.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech säljer SBL Vaccin till PowderJect Pharmaceuticals ]]></title>
<pubDate>Tue, 3 Jul 2001 08:18:10 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200107/826401.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Positive results reported by Active Biotech's TTS Phase I cancer study]]></title>
<pubDate>Tue, 26 Jun 2001 15:33:50 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200106/825901.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Positiva resultat från Active Biotechs TTS Fas I cancerstudie ]]></title>
<pubDate>Tue, 26 Jun 2001 09:12:06 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200106/825829.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[The Active Biotech Group Interim Report January - March 2001]]></title>
<pubDate>Mon, 14 May 2001 16:56:03 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200105/820945.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech-koncernen Kvartalsrapport januari-mars 2001]]></title>
<pubDate>Wed, 9 May 2001 17:22:46 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200105/820175.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech-koncernen Bokslutskommuniké för verksamhetsåret 2000]]></title>
<pubDate>Thu, 15 Feb 2001 15:36:55 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200102/808897.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech-koncernen: Delårsrapport januari - september 2000]]></title>
<pubDate>Thu, 16 Nov 2000 16:30:50 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200011/798121.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech receives major new order for SBL Cholera Vaccine worth MSEK 11.5]]></title>
<pubDate>Wed, 25 Oct 2000 12:24:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200010/794315.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech erhåller ny stor order på SBL Cholera Vaccine, värd 11,5 mkr]]></title>
<pubDate>Tue, 24 Oct 2000 13:52:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200010/794088.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[ACTIVE BIOTECH - EXTRA SHAREHOLDERS´ MEETING 19 OCTOBER 2000]]></title>
<pubDate>Thu, 19 Oct 2000 16:56:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200010/793725.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[EXTRA BOLAGSSTÄMMA - ACTIVE BIOTECH 19 OKTOBER 2000.]]></title>
<pubDate>Thu, 19 Oct 2000 16:54:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200010/793724.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[The Active Biotech Group Half-Year Accounts January - June 2000]]></title>
<pubDate>Fri, 18 Aug 2000 17:26:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200008/788150.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech-koncernen Halvårsbokslut januari - juni 2000]]></title>
<pubDate>Thu, 17 Aug 2000 15:29:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200008/787988.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech and SmithKline Beecham agree to close collaboration regarding vaccines against traveller’s diarrhoea]]></title>
<pubDate>Tue, 8 Aug 2000 11:41:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200008/786761.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech och SmithKline Beecham avtalar om att avsluta samarbetet kring vaccin mot turistdiarré]]></title>
<pubDate>Tue, 8 Aug 2000 11:40:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200008/786758.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech concludes agreement with Aventis Pasteur]]></title>
<pubDate>Tue, 8 Aug 2000 09:19:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200008/786733.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech tecknar avtal med Aventis Pasteur]]></title>
<pubDate>Tue, 8 Aug 2000 09:17:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200008/786732.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB accepts offer from Carl Bennet AB on shares in Lifco AB]]></title>
<pubDate>Wed, 2 Aug 2000 12:18:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200008/786375.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB accepterar Carl Bennet ABs bud på aktier i Lifco AB]]></title>
<pubDate>Wed, 2 Aug 2000 12:16:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200008/786374.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Quarterly Report January - March 2000]]></title>
<pubDate>Fri, 26 May 2000 14:51:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200005/782408.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Kvartalsrapport januari - mars 2000]]></title>
<pubDate>Thu, 25 May 2000 15:17:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200005/782313.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[ACTIVE BIOTECH SHAREHOLDERS' MEETING 12 APRIL 2000]]></title>
<pubDate>Fri, 14 Apr 2000 17:11:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200004/777828.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Flaggningsmeddelande]]></title>
<pubDate>Thu, 13 Apr 2000 09:08:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200004/777423.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[ACTIVE BIOTECHS BOLAGSTÄMMA 12 APRIL 2000]]></title>
<pubDate>Thu, 13 Apr 2000 08:58:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200004/777421.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[MGA Holding ny storägare i Active Biotech AB]]></title>
<pubDate>Thu, 13 Apr 2000 07:30:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200004/777409.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Bo Håkanssons inledningsanförande vid Active Biotechs bolagsstämma 2000-04-12]]></title>
<pubDate>Thu, 13 Apr 2000 07:28:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200004/777408.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Preliminary results from the first Phase lll-study of the ETEC-vaccine]]></title>
<pubDate>Wed, 29 Mar 2000 09:24:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200003/774578.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Preliminära resultat från Fas III-studier av ETEC-vaccinet ]]></title>
<pubDate>Wed, 29 Mar 2000 09:23:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200003/774577.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation to Annual Meeting of Shareholders]]></title>
<pubDate>Wed, 15 Mar 2000 12:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200003/773667.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Kallelse till bolagsstämma]]></title>
<pubDate>Wed, 15 Mar 2000 11:15:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200003/773660.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Patent for SAIK-MS approved in the USA]]></title>
<pubDate>Thu, 2 Mar 2000 09:25:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200003/772729.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Patent för SAIK-MS beviljat i USA]]></title>
<pubDate>Tue, 29 Feb 2000 16:07:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200002/772542.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Group Annual Accounts Report January - December 1999]]></title>
<pubDate>Mon, 21 Feb 2000 15:08:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200002/771671.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Bokslutskommuniké januari - december 1999]]></title>
<pubDate>Fri, 18 Feb 2000 08:56:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200002/771512.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[The Swedish Medical Products Agency has approved for Active Biotech to expand Phase I-trials and include patients with multiple sclerosis]]></title>
<pubDate>Fri, 11 Feb 2000 15:41:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200002/770667.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Läkemedelsverket har godkänt att Active Biotech genomför en utvidgad Fas I-prövning som även inkluderar patienter med sjukdomen multipel skleros ]]></title>
<pubDate>Fri, 11 Feb 2000 11:33:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200002/770619.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[New production manager for Active Biotech]]></title>
<pubDate>Mon, 10 Jan 2000 15:15:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/200001/768557.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Ny produktionschef till Active Biotech]]></title>
<pubDate>Wed, 22 Dec 1999 15:36:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199912/767940.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[PRESS RELEASE]]></title>
<pubDate>Wed, 22 Dec 1999 12:30:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199912/767919.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[PRESSRELEASE                       ]]></title>
<pubDate>Tue, 21 Dec 1999 15:56:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199912/767856.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Group Interim Report 1 January - 30 September 1999<br>]]></title>
<pubDate>Wed, 24 Nov 1999 15:05:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199911/766500.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech-koncernen Delårsrapport 1 januari - 30 september 1999]]></title>
<pubDate>Mon, 22 Nov 1999 13:20:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199911/766336.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Altered day regarding financial information for Active Biotech]]></title>
<pubDate>Fri, 12 Nov 1999 10:29:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199911/765937.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Ändrad rapportdag för Active Biotech ]]></title>
<pubDate>Fri, 12 Nov 1999 10:29:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199911/765936.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Increased institutional ownership in Active Biotech]]></title>
<pubDate>Fri, 24 Sep 1999 14:15:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199909/763055.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Ökat institutionellt ägande i Active Biotech]]></title>
<pubDate>Fri, 24 Sep 1999 08:49:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199909/763031.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Half Year Report January - June 1999]]></title>
<pubDate>Fri, 27 Aug 1999 14:51:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199908/762110.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech-koncernen Halvårsbokslut januari - juni 1999]]></title>
<pubDate>Thu, 26 Aug 1999 15:45:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199908/762065.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech gets international order for cholera vaccine after recommendation from WHO]]></title>
<pubDate>Tue, 3 Aug 1999 10:50:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199908/760526.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech får internationell order på koleravaccin efter rekommendation av WHO]]></title>
<pubDate>Mon, 2 Aug 1999 17:58:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199908/760485.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's drug against MS in Phase I trials 6 months ahead of plan]]></title>
<pubDate>Tue, 29 Jun 1999 14:42:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199906/759753.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs läkemedel mot MS 6 månader tidigare i fas I ]]></title>
<pubDate>Mon, 28 Jun 1999 14:52:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199906/759718.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech and OXiGENE enter into research collaboration within the field of inflammatory diseases]]></title>
<pubDate>Wed, 16 Jun 1999 14:21:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199906/759347.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech och OXiGENE inleder forskningssamarbete inom området inflammation]]></title>
<pubDate>Wed, 16 Jun 1999 09:48:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199906/759324.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech gains strength with a new Head of Preclinical Research]]></title>
<pubDate>Tue, 8 Jun 1999 14:22:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199906/759099.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech förstärker med ny preklinisk forskningschef]]></title>
<pubDate>Mon, 7 Jun 1999 09:09:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199906/759022.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Notering av aktierna i Wilh. Sonesson AB (publ) på O-listan vid Stockholms Fondbörs]]></title>
<pubDate>Mon, 31 May 1999 10:04:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199905/758758.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[The Active Biotech Group Quarterly Report January - March 1999]]></title>
<pubDate>Thu, 20 May 1999 16:58:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199905/758478.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech-koncernen Kvartalsrapport januari - mars 1999]]></title>
<pubDate>Mon, 17 May 1999 15:23:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199905/758301.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Topics from the Managing Director's Speech at the Annual General Meeting of  Active Biotech]]></title>
<pubDate>Wed, 12 May 1999 11:24:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199905/758234.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Många nyheter i VD-talet på Active Biotechs bolagsstämma]]></title>
<pubDate>Tue, 11 May 1999 10:17:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199905/758101.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Tidplan för utdelning av Wilh. Sonesson AB]]></title>
<pubDate>Thu, 29 Apr 1999 11:48:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199904/757366.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Invitation to Annual Meeting of Shareholders]]></title>
<pubDate>Fri, 23 Apr 1999 16:11:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199904/756654.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Kallelse till Bolagsstämma]]></title>
<pubDate>Fri, 23 Apr 1999 16:09:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199904/756652.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Årsredovisning 1998 ]]></title>
<pubDate>Thu, 22 Apr 1999 11:57:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199904/756517.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech satsar på cancerdiagnostik ]]></title>
<pubDate>Mon, 29 Mar 1999 15:17:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199903/755341.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech concentrates upon cancer diagnostics ]]></title>
<pubDate>Mon, 29 Mar 1999 15:06:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199903/755336.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Group Annual Accounts Report January - December 1998]]></title>
<pubDate>Mon, 1 Mar 1999 16:59:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199903/754023.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Bokslutskommuniké januari - december 1998]]></title>
<pubDate>Thu, 25 Feb 1999 14:18:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199902/753819.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[NOVEL PRODUCT IDENTIFIED FOR TOOTH DECAY]]></title>
<pubDate>Fri, 15 Jan 1999 10:20:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199901/751583.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech acquires 100 % in Transport AB Movera]]></title>
<pubDate>Tue, 29 Dec 1998 14:05:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199812/751166.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech forvärvar 100 % i Transport AB Movera]]></title>
<pubDate>Mon, 28 Dec 1998 16:46:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199812/751155.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech sells its real estate in Lund for SEK 320 M with a capital gain of SEK 80M]]></title>
<pubDate>Tue, 22 Dec 1998 14:48:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199812/751022.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech säljer sin fastighet i Lund for 320 mkr med en realisationsvinst på 80 mkr]]></title>
<pubDate>Tue, 22 Dec 1998 14:47:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199812/751020.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Sven Andréasson ny VD i Active Biotech]]></title>
<pubDate>Wed, 16 Dec 1998 16:06:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199812/750757.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Sven Andréasson new President & CEO of Active Biotech]]></title>
<pubDate>Wed, 16 Dec 1998 12:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199812/833342.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech Group Interim Report 1 January - 30 September 1998]]></title>
<pubDate>Thu, 19 Nov 1998 14:52:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199811/750142.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Delårsrapport 1 januari - 30 september 1998]]></title>
<pubDate>Thu, 19 Nov 1998 12:12:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199811/715467.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[BioPhausia and Active Biotech to co-operate in cancer project]]></title>
<pubDate>Tue, 17 Nov 1998 13:29:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199811/715444.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[BioPhausia och Active Biotech i samarbete om cancerprojekt.]]></title>
<pubDate>Tue, 17 Nov 1998 10:31:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199811/715403.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[FLAGGNINGSMEDDELANDE]]></title>
<pubDate>Mon, 7 Sep 1998 12:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199809/582100.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[SUBSTANTIAL ACQUISITION OF SHARES]]></title>
<pubDate>Mon, 7 Sep 1998 12:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199809/582000.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Very high level of participation in Active Biotech's warrants programme for personnel]]></title>
<pubDate>Thu, 2 Jul 1998 12:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199807/833340.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Mycket stor anslutning till Active Biotechs personaloptioner]]></title>
<pubDate>Thu, 2 Jul 1998 12:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199807/833075.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech steps up efforts in ETEC and cholera vaccine through acquisition of VITEC]]></title>
<pubDate>Mon, 29 Jun 1998 12:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199806/833339.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech ökar satsningen på ETEC- och koleravaccin genom förvärv av Vitec]]></title>
<pubDate>Mon, 29 Jun 1998 12:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199806/833073.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech AB's directed new share issue fully subscribed]]></title>
<pubDate>Fri, 5 Jun 1998 12:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199806/833336.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech ABs riktade nyemission fulltecknad]]></title>
<pubDate>Fri, 5 Jun 1998 12:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199806/434500.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[New issue fully subscribed]]></title>
<pubDate>Wed, 20 May 1998 12:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199805/833335.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Nyemissionen fulltecknad]]></title>
<pubDate>Wed, 20 May 1998 12:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199805/833071.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech's Annual General Meeting approved the acquisition of the Lund Research Center]]></title>
<pubDate>Fri, 17 Apr 1998 12:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199804/833333.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotechs bolagsstämma godkände förvärvet av Lund Research Center]]></title>
<pubDate>Fri, 17 Apr 1998 12:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199804/351300.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech renodlar - säljer Rederi AB Heron. Soliditeten ökar från 34% till 49%.

]]></title>
<pubDate>Thu, 2 Apr 1998 12:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199804/330500.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Nyemissioner i Active Biotech]]></title>
<pubDate>Tue, 31 Mar 1998 12:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199803/327600.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Ny forskningschef i Active Biotech]]></title>
<pubDate>Tue, 10 Mar 1998 12:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199803/297600.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[New Head of Research at Active Biotech]]></title>
<pubDate>Tue, 10 Mar 1998 10:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199803/298900.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech - new force in biotechnology]]></title>
<pubDate>Mon, 9 Mar 1998 12:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199803/833328.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech ny kraft inom bioteknik]]></title>
<pubDate>Mon, 9 Mar 1998 12:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199803/295700.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Bokslutskommuniké för 1997]]></title>
<pubDate>Thu, 26 Feb 1998 12:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199802/281000.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Active Biotech acquires Lund Research Center from Pharmacia & Upjohn]]></title>
<pubDate>Fri, 19 Dec 1997 00:00:00 +0100</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199712/230520.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[ACTIVE becomes Active Biotech - operations concentrated on biotechnology]]></title>
<pubDate>Mon, 20 Oct 1997 12:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199710/833327.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[ACTIVE to concentrate on biotechnology]]></title>
<pubDate>Sun, 5 Oct 1997 12:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199710/833326.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[Agreement with Swedish Government on acquisition of SBL Vaccin AB]]></title>
<pubDate>Thu, 29 May 1997 12:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199705/833324.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[SBL Vaccin acquisition approved by ACTIVE's Annual General Meeting]]></title>
<pubDate>Tue, 13 May 1997 12:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199705/833322.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

<item>
<title><![CDATA[ACTIVE acquires SBL Vaccin AB from the Swedish State]]></title>
<pubDate>Mon, 12 May 1997 12:00:00 +0200</pubDate>
<link>http://cws.huginonline.com/A/1002/PR/199705/833321.xml</link>
<source url="http://www.kunde.com">Active Biotech</source>
</item>

</channel>
</rss>


